These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22958096)

  • 41. [Lichenoid drug reaction to leflunomide].
    Canonne-Courivaud D; Carpentier O; Dejobert Y; Hachulla E; Delaporte E
    Ann Dermatol Venereol; 2003 Apr; 130(4):435-7. PubMed ID: 12843855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial.
    Poór G; Strand V;
    Rheumatology (Oxford); 2004 Jun; 43(6):744-9. PubMed ID: 15026583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leflunomide can potentiate the anticoagulant effect of warfarin.
    Lim V; Pande I
    BMJ; 2002 Dec; 325(7376):1333. PubMed ID: 12468482
    [No Abstract]   [Full Text] [Related]  

  • 44. [Application of leflunomide in the treatment of patients with rheumatoid arthritis].
    Kucharz EJ
    Pol Arch Med Wewn; 2001 Feb; 105(2):177-82. PubMed ID: 11505754
    [No Abstract]   [Full Text] [Related]  

  • 45. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leflunomide for the treatment of rheumatoid arthritis.
    Olsen NJ; Strand V; Kremer JM
    Bull Rheum Dis; 1999; 48(8):1-4. PubMed ID: 10628065
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Leflunomide plus methotrexate. Hope for patients with rheumatoid arthritis].
    MMW Fortschr Med; 2001 Aug; 143(33-34):56-7. PubMed ID: 11561463
    [No Abstract]   [Full Text] [Related]  

  • 49. [Leflunomide in the treatment of rheumatoid arthritis].
    Kochbati S; Ben Miled M; Boussema F; Ktari S; Daoud L; Ben Rhouma S; Ben Amor G; Chérif O; Rokbani L
    Tunis Med; 2005 Feb; 83(2):91-7. PubMed ID: 15969231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subacute cutaneous lupus erythematosus associated with leflunomide.
    Kerr OA; Murray CS; Tidman MJ
    Clin Exp Dermatol; 2004 May; 29(3):319-20. PubMed ID: 15115526
    [No Abstract]   [Full Text] [Related]  

  • 51. [Leflunomide: a new treatment for an old disease].
    Monteagudo Sáez I; López Longo FJ; González Fernández CM; Carreño Pérez L
    Rev Clin Esp; 2000 May; 200 Monog 1():114-8. PubMed ID: 10901036
    [No Abstract]   [Full Text] [Related]  

  • 52. Neuropathy associated with leflunomide: a case series.
    Martin K; Bentaberry F; Dumoulin C; Longy-Boursier M; Lifermann F; Haramburu F; Dehais J; Schaeverbeke T; Bégaud B; Moore N
    Ann Rheum Dis; 2005 Apr; 64(4):649-50. PubMed ID: 15769926
    [No Abstract]   [Full Text] [Related]  

  • 53. Leflunomide-induced lung injury that developed after its withdrawal, coinciding with peripheral blood lymphocyte count decrease.
    Otsuka T; Koyama T; Ohtani R; Niiro H; Yoshizawa S; Harada M; Inokuma S
    Mod Rheumatol; 2008; 18(1):96-9. PubMed ID: 18161003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffuse alveolar hemorrhage after leflunomide therapy in a patient with rheumatoid arthritis.
    Carloni A; Piciucchi S; Giannakakis K; Nori G; Zobel BB; Poletti V
    J Thorac Imaging; 2008 Feb; 23(1):57-9. PubMed ID: 18347524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
    Silverman E; Spiegel L; Hawkins D; Petty R; Goldsmith D; Schanberg L; Duffy C; Howard P; Strand V
    Arthritis Rheum; 2005 Feb; 52(2):554-62. PubMed ID: 15693001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leflunomide-associated weight loss in rheumatoid arthritis.
    Coblyn JS; Shadick N; Helfgott S
    Arthritis Rheum; 2001 May; 44(5):1048-51. PubMed ID: 11352235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rheumatoid arthritis treatment with weekly leflunomide: an open-label study.
    Jaimes-Hernández J; Robles-San Román M; Suárez-Otero R; Dávalos-Zugasti ME; Arroyo-Borrego S
    J Rheumatol; 2004 Feb; 31(2):235-7. PubMed ID: 14760790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Methotrexate combined with leflunomide or hydroxychloroquine in the treatment of rheumatoid arteritis].
    Zhang X; Cui Y; Luo rQ; Yao RY; Zhou H
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1038-40. PubMed ID: 15312543
    [No Abstract]   [Full Text] [Related]  

  • 59. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M; Creemers MC; Welsing PM; van Riel PL
    Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction.
    Kamata Y; Nara H; Kamimura T; Haneda K; Iwamoto M; Masuyama J; Okazaki H; Minota S
    Intern Med; 2004 Dec; 43(12):1201-4. PubMed ID: 15645660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.